These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22374155)

  • 1. Reducing oral flora contamination of intravitreal injections with face mask or silence.
    Doshi RR; Leng T; Fung AE
    Retina; 2012 Mar; 32(3):473-6. PubMed ID: 22374155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial dispersal associated with speech in the setting of intravitreous injections.
    Wen JC; McCannel CA; Mochon AB; Garner OB
    Arch Ophthalmol; 2011 Dec; 129(12):1551-4. PubMed ID: 21825179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.
    Shimada H; Hattori T; Mori R; Nakashizuka H; Fujita K; Yuzawa M
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1885-90. PubMed ID: 23389553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of diluting povidone-iodine on bacterial growth associated with speech.
    Gnanasekaran S; Rogers S; Wickremasinghe S; Sandhu SS
    BMC Ophthalmol; 2019 Feb; 19(1):62. PubMed ID: 30808316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Povidone-iodine contact time and lid speculum use during intravitreal injection.
    Friedman DA; Mason JO; Emond T; McGwin G
    Retina; 2013 May; 33(5):975-81. PubMed ID: 23416514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of povidone-iodine concentration and exposure time on bacteria isolated from endophthalmitis cases.
    Hosseini H; Ashraf MJ; Saleh M; Nowroozzadeh MH; Nowroozizadeh B; Abtahi MB; Nowroozizadeh S
    J Cataract Refract Surg; 2012 Jan; 38(1):92-6. PubMed ID: 21983301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    Patel SN; Hsu J; Sivalingam MD; Chiang A; Kaiser RS; Mehta S; Park CH; Regillo CD; Sivalingam A; Vander JF; Ho AC; Garg SJ;
    Am J Ophthalmol; 2021 Feb; 222():194-201. PubMed ID: 32888902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing oral contamination during corneal scrapes.
    Samarawickrama C; Li YC; Carnt N; Willcox M; Dutta D; Watson S
    BMJ Open Ophthalmol; 2017; 1(1):e000044. PubMed ID: 29354701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival.
    Boden JH; Myers ML; Lee T; Bushley DM; Torres MF
    J Cataract Refract Surg; 2008 Oct; 34(10):1773-5. PubMed ID: 18812132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections.
    Patel SN; Mahmoudzadeh R; Salabati M; Soares RR; Hinkle J; Hsu J; Garg SJ; Regillo CD; Ho AC; Cohen MN; Khan MA; Yonekawa Y; Chiang A; Gupta OP; Kuriyan AE
    Am J Ophthalmol; 2021 Mar; 223():178-183. PubMed ID: 33129809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual application versus single application of povidone-iodine in reducing surgical site contamination during strabismus surgery.
    Benson CE; Rogers KL; Suh DW
    J AAPOS; 2014 Aug; 18(4):347-50. PubMed ID: 25173897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    ; Patel SN; Tang PH; Storey PP; Wolfe JD; Fein J; Shah SP; Chen E; Abbey A; Ferrone PJ; Shah CP; Liang MC; Stem MS; Ali Khan M; Yonekawa Y; Garg SJ
    Ophthalmology; 2021 Nov; 128(11):1620-1626. PubMed ID: 34019955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Povidone-iodine for endophthalmitis prophylaxis.
    Ahmed Y; Scott IU; Pathengay A; Bawdekar A; Flynn HW
    Am J Ophthalmol; 2014 Mar; 157(3):503-4. PubMed ID: 24528933
    [No Abstract]   [Full Text] [Related]  

  • 14. Face Masks and Bacterial Dispersion Toward the Periocular Area.
    Raevis JJ; Gjyzeli G; Mititelu M; Rogers J; Lasarev M; Chang JS
    Ophthalmology; 2021 Aug; 128(8):1236-1238. PubMed ID: 33444660
    [No Abstract]   [Full Text] [Related]  

  • 15. No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting.
    Brynskov T; Kemp H; Sørensen TL
    Retina; 2014 May; 34(5):951-7. PubMed ID: 24317292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FACE MASK CONTAMINATION DURING COVID-19 PANDEMIA. A STUDY ON PATIENTS RECEIVING INTRAVITREAL INJECTIONS.
    Marín-Nieto J; Reino-Perez C; Santillana-Cernuda G; Díaz-Bernal JM; Luque-Aranda R; García-Basterra I
    Retina; 2021 Nov; 41(11):2215-2220. PubMed ID: 33965993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Methods to Reduce Endophthalmitis After Intravitreal Injection.
    Kim SJ; Fine HF
    Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):996-1000. PubMed ID: 26599240
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of recurrent povidone-iodine usage on conjunctival flora in diabetic patients undergoing intravitreal injections.
    Einan-Lifshitz A; Sorkin N; Smollan G; Barequet I
    Eur J Ophthalmol; 2021 Mar; 31(2):607-611. PubMed ID: 31983226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lidocaine gel anesthesia on endophthalmitis rates following intravitreal injection.
    Lad EM; Maltenfort MG; Leng T
    Ophthalmic Surg Lasers Imaging; 2012; 43(2):115-20. PubMed ID: 22283227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the risk of endophthalmitis after intravitreous injection.
    Kim SJ; Chomsky AS; Sternberg P
    JAMA Ophthalmol; 2013 May; 131(5):674-5. PubMed ID: 23699844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.